Dr. FAEZEH MAGHSOOD | Infectious disease | Best Researcher Award

Faezeh Maghsood (b. January 5, 1990, Iran)  is a highly skilled immunologist specializing in vaccine development, monoclonal antibodies, and immunotherapy for cancer and infectious diseases.  With a B.Sc., M.Sc., and Ph.D. in Medical Immunology from Tehran University of Medical Sciences (TUMS), she has consistently ranked at the top throughout her academic journey.  She currently works as a Research Associate at TUMS and has previously held positions at the Pasteur Institute of Iran and renowned clinical labs. Her Ph.D. work focused on SARS-CoV-2 monoclonal antibody production, earning her multiple prestigious awards.  She has contributed to peer-reviewed journals and actively participates in global scientific events, including immunology congresses in Japan  and Iran. Faezeh is passionate about cutting-edge biomedical research, particularly tumor immunology and stem cells, and continues to push the boundaries in translational medicine.

Profile

Scholar

Education

Faezeh earned her B.Sc. in Medical Laboratory Sciences (2008–2012) from TUMS with a GPA of 18.33/20, showcasing her early interest in clinical diagnostics. She pursued her M.Sc. in Medical Immunology (2012–2016) at the same university, achieving an impressive GPA of 19.32/20, and researched probiotics’ effects on MMPs and immune markers . Her Ph.D. in Medical Immunology (2018–2023) was also from TUMS, with a GPA of 18.61/20, culminating in a thesis on the structural and functional characterization of neutralizing mouse monoclonal antibodies against SARS-CoV-2 under the supervision of Prof. Fazel Shokri and Dr. Amiri . Her academic journey reflects a strong foundation in both theoretical and applied aspects of immunological sciences, bolstered by exceptional talent recognition and consistent academic excellence .

Experience

Faezeh currently serves as a Research Associate at Tehran University of Medical Sciences (2024–Present), where she contributes to cutting-edge immunology research . Previously, she worked as a Research Assistant and Lab Manager (2015–2018) at the Pasteur Institute of Iran’s Biochemistry Department in the Stem Cell Lab . Her clinical background includes valuable roles in diagnostic laboratories at Shariati Hospital and Imam Khomeini Hospital during 2011–2012 . This diverse experience combines academic research, lab management, and hands-on clinical diagnostics, equipping her with a comprehensive skillset in experimental design, immunoassays, and lab operations . She actively participates in international training programs, enhancing her knowledge in genome editing, CRISPR/Cas9, RNA-seq, and R programming .

Awards & Honors

Faezeh has received several notable accolades, including 3rd place in the M8 Alliance Best PhD Thesis Prize (2024)  and selection as Best PhD Thesis at TUMS . She was ranked 1st nationally in Iran’s 2018 Ph.D. entrance exam in medical sciences . During her M.Sc. studies, she was acknowledged as an exceptionally talented student at TUMS’s Faculty of Allied Medicine (2012) and was the top student throughout her undergraduate years (2008–2012) . These achievements highlight her unwavering dedication, academic excellence, and research leadership . Faezeh’s accomplishments reflect a persistent pursuit of innovation and a strong commitment to contributing meaningfully to global scientific advancement, particularly in the fields of immunotherapy and biomedical diagnostics .

Research Focus

Faezeh’s research is deeply rooted in medical immunology, with core interests in vaccine development, monoclonal antibody production, and immunotherapy for cancer and infectious diseases . Her Ph.D. project involved the creation and detailed analysis of neutralizing monoclonal antibodies targeting SARS-CoV-2, highlighting her expertise in virology and structural immunology . She is also passionate about tumor immunology, exploring immune mechanisms in oncology, and advancing stem cell-based therapies . Faezeh is dedicated to bridging basic science with clinical application, using advanced methods like flow cytometry, CRISPR/Cas9 editing, RNA-Seq, and bioinformatics for translational immunological research . Her interdisciplinary focus aims to address global health challenges through innovation, collaboration, and precision medicine.

 Conclusion

Dr. Faezeh Maghsood is an exceptionally promising early-career researcher in medical immunology with a strong academic foundation, robust research outputs, and international exposure. Her work on monoclonal antibodies and SARS-CoV-2 is not only timely but also highly significant in the global health landscape. While she is still in the early stages of building a fully independent research portfolio, her trajectory, productivity, and recognition make her a highly suitable and worthy candidate for a Best Researcher Award, particularly in the early-career or emerging investigator category.

Publication

1. Title: Hypoxia pre-conditioned embryonic mesenchymal stem cell secretome reduces IL-10 production by peripheral blood mononuclear cells
   Year: 2017
   Authors: M Lotfinia, S Lak, NM Ghahhari, B Johari, F Maghsood, S Parsania, …
   Citation: 45

 

1. Title: Anti-proliferative and Anti-metastatic Potential of High Molecular Weight Secretory Molecules from Probiotic Lactobacillus Reuteri Cell-Free Supernatant Against …
   Year: 2020
   Authors: F Maghsood, B Johari, M Rohani, H Madanchi, Z Saltanatpour, M Kadivar
   Citation: 44

 

1. Title: Dual effects of cell free supernatants from Lactobacillus acidophilus and Lactobacillus rhamnosus GG in regulation of MMP-9 by up-regulating TIMP-1 and down-regulating CD147 in …
   Year: 2017
   Authors: F Maghsood, A Mirshafiey, MM Farahani, MH Modarressi, P Jafari, …
   Citation: 43

 

1. Title: Myc decoy oligodeoxynucleotide inhibits growth and modulates differentiation of mouse embryonic stem cells as a model of cancer stem cells
   Year: 2017
   Authors: B Johari, M Ebrahimi-Rad, F Maghsood, M Lotfinia, Z Saltanatpouri, …
   Citation: 23

 

1. Title: SARS‐CoV‐2 nucleocapsid: Biological functions and implication for disease diagnosis and vaccine design
   Year: 2023
   Authors: F Maghsood, A Ghorbani, H Yadegari, F Golsaz‐Shirazi, MM Amiri, …
   Citation: 17

 

1. Title: Diagnostic performance of a novel antigen-capture ELISA for the detection of SARS-CoV-2
   Year: 2023
   Authors: H Yadegari, M Mohammadi, F Maghsood, A Ghorbani, T Bahadori, …
   Citation: 16

 

1. Title: Does prior immunization with measles, mumps, and rubella vaccines contribute to the antibody response to COVID-19 antigens?
   Year: 2021
   Authors: D Hassani, MM Amiri, F Maghsood, V Salimi, GA Kardar, O Barati, …
   Citation: 16

 

1. Title: Epitope mapping of severe acute respiratory syndrome coronavirus 2 neutralizing receptor binding domain-specific monoclonal antibodies
   Year: 2022
   Authors: F Maghsood, MM Amiri, AH Zarnani, V Salimi, GA Kardar, J Khoshnoodi, …
   Citation: 14

 

1. Title: The effect of Trimetazidine and Diazoxide on immunomodulatory activity of human embryonic stem cell-derived mesenchymal stem cell secretome
   Year: 2017
   Authors: S Jahandideh, F Maghsood, NM Ghahhari, M Lotfinia, M Mohammadi, …
   Citation: 14

 

1. Title: Epitope mapping of neutralising anti‐SARS‐CoV‐2 monoclonal antibodies: implications for immunotherapy and vaccine design
   Year: 2022
   Authors: S Ghotloo, F Maghsood, F Golsaz‐Shirazi, MM Amiri, C Moog, F Shokri
   Citation: 12

 

1. Title: Identification of immunodominant epitopes on nucleocapsid and spike proteins of the SARS-CoV-2 in Iranian COVID-19 patients
   Year: 2022
   Authors: F Maghsood, MR Shokri, M Jeddi-Tehrani, M Torabi Rahvar, A Ghaderi, …
   Citation: 11

 

1. Title: Inhibition of transcription factor T‐cell factor 3 (TCF3) using the oligodeoxynucleotide strategy increases embryonic stem cell stemness: Possible application in regenerative …
   Year: 2019
   Authors: B Johari, Z Asadi, E Rismani, F Maghsood, Z Sheikh Rezaei, S Farahani, …
   Citation: 11

 

1. Title: Anti-inflammatory property of β-D-mannuronic acid (M2000) on expression and activity of matrix metalloproteinase-2 and-9 through CD147 molecule in phorbol myristate acetate …
   Year: 2017
   Authors: MM Farahani, E Motevaseli, F Maghsood, M Heidari-Kharaji, A Mirshafiey
   Citation: 11